GUARDANT HEALTH, INC. Revenue from Contract with Customer, Excluding Assessed Tax
GUARDANT HEALTH, INC. (GH) reported Revenue from Contract with Customer, Excluding Assessed Tax of $334.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-30
- GUARDANT HEALTH, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $334.98M, a 44.33% increase year-over-year.
- GUARDANT HEALTH, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $301.67M, a 48.26% increase year-over-year.
- GUARDANT HEALTH, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $281.27M, a 39.37% increase year-over-year.
- GUARDANT HEALTH, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $265.20M, a 38.50% increase year-over-year.
- GUARDANT HEALTH, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $982.02M, a 32.88% increase from fiscal 2024.
- GUARDANT HEALTH, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $739.02M, a 31.04% increase from fiscal 2023.
- GUARDANT HEALTH, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $563.95M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $334.98M 10-Q · filed 2026-07-30 | $636.64M 10-Q · filed 2026-07-30 | $917.91M derived: sum of 3 quarters · filed 2026-07-30 | $1.18B derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $301.67M 10-Q · filed 2026-05-07 | $582.93M derived: sum of 2 quarters · filed 2026-05-07 | $848.13M derived: sum of 3 quarters · filed 2026-05-07 | $1.08B derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $281.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $546.46M derived: sum of 2 quarters · filed 2026-02-19 | $778.55M derived: sum of 3 quarters · filed 2026-07-30 | $982.02M 10-K · filed 2026-02-19 |
| 2025-09-30 | $265.20M 10-Q · filed 2025-10-29 | $497.28M derived: sum of 2 quarters · filed 2026-07-30 | $700.75M 10-Q · filed 2025-10-29 | $902.57M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $232.09M 10-Q · filed 2026-07-30 | $435.56M 10-Q · filed 2026-07-30 | $637.37M derived: sum of 3 quarters · filed 2026-07-30 | $828.85M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $203.47M 10-Q · filed 2026-05-07 | $405.29M derived: sum of 2 quarters · filed 2026-05-07 | $596.76M derived: sum of 3 quarters · filed 2026-05-07 | $774.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $201.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $393.29M derived: sum of 2 quarters · filed 2026-02-19 | $570.52M derived: sum of 3 quarters · filed 2026-02-19 | $739.02M 10-K · filed 2026-02-19 |
| 2024-09-30 | $191.48M 10-Q · filed 2025-10-29 | $368.71M derived: sum of 2 quarters · filed 2025-10-29 | $537.20M 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $177.24M 10-Q · filed 2025-07-30 | $345.73M 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $168.49M 10-Q · filed 2025-04-30 | |||
| 2023-12-31 | $563.95M 10-K · filed 2026-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |